ASTERIAS BIOTHERAPEUTICS INC's ticker is AST and the CUSIP is 04624N107. A total of 56 filers reported holding ASTERIAS BIOTHERAPEUTICS INC in Q4 2015. The put-call ratio across all filers is 339.00 and the average weighting 0.0%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q4 2018 | $0 | -100.0% | 568 | +7.8% | 0.00% | – |
| Q3 2018 | $1,000 | 0.0% | 527 | 0.0% | 0.00% | – |
| Q2 2018 | $1,000 | 0.0% | 527 | 0.0% | 0.00% | – |
| Q1 2018 | $1,000 | 0.0% | 527 | 0.0% | 0.00% | – |
| Q4 2017 | $1,000 | -50.0% | 527 | 0.0% | 0.00% | – |
| Q3 2017 | $2,000 | 0.0% | 527 | 0.0% | 0.00% | – |
| Q2 2017 | $2,000 | 0.0% | 527 | 0.0% | 0.00% | – |
| Q1 2017 | $2,000 | 0.0% | 527 | 0.0% | 0.00% | – |
| Q4 2016 | $2,000 | 0.0% | 527 | 0.0% | 0.00% | – |
| Q3 2016 | $2,000 | – | 527 | +584.4% | 0.00% | – |
| Q2 2016 | $0 | -100.0% | 77 | -99.0% | 0.00% | – |
| Q1 2016 | $38,000 | +18.8% | 7,973 | 0.0% | 0.00% | – |
| Q4 2015 | $32,000 | +68.4% | 7,973 | +58.2% | 0.00% | – |
| Q3 2015 | $19,000 | -17.4% | 5,041 | 0.0% | 0.00% | – |
| Q2 2015 | $23,000 | -42.5% | 5,041 | -16.6% | 0.00% | – |
| Q1 2015 | $40,000 | – | 6,041 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| BROADWOOD CAPITAL INC | 5,292,156 | $7,144,000 | 0.82% |
| Northeast Financial Consultants Inc | 732,265 | $988,000 | 0.30% |
| Family Management Corp | 10,424 | $14,000 | 0.01% |
| LMR Partners LLP | 81,550 | $110,000 | 0.01% |
| ELEMENT CAPITAL MANAGEMENT LLC | 148,528 | $201,000 | 0.01% |
| Poehling Capital Management, INC. | 3,302 | $4,000 | 0.00% |
| Paloma Partners Management Co | 143,800 | $194,000 | 0.00% |
| Founders Capital Management | 3,000 | $4,000 | 0.00% |
| BRIDGEWAY CAPITAL MANAGEMENT, LLC | 186,254 | $251,000 | 0.00% |
| FNY Investment Advisers, LLC | 4,230 | $5,000 | 0.00% |